In spite of a government shutdown that has challenged operations at many federal agencies, the U.S. Food and Drug Administration has posted the videotapes of the Sept. 24, 2013 Patient-Focused Drug Development Initiative meeting on narcolepsy. The recording includes viewing windows that show the speaker, the slides used by the speaker and a transcript.
View the recording at:
- Part 1: https://collaboration.fda.gov/p2phbazfvia/?launcher=false&fcsContent=true&pbMode=normal
- Part 2: https://collaboration.fda.gov/p3b3qbgldex/?launcher=false&fcsContent=true&pbMode=normal
All FDA links related to the narcolepsy meeting are available at: http://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm359018.htm
We will post a detailed meeting summary in the next day or two.
There’s still time to make sure your voice is heard. Here are two ways you can share your experience and perspectives:
- Complete the Survey: Take 15-20 minutes to respond to the Unite Narcolepsy Patient-Focused Survey based on FDA’s questions and other issues important to narcolepsy patients: https://www.surveymonkey.com/s/unitenarcolepsy All survey responses received by November 15, 2013 will be submitted to FDA before the November 25, 2013 deadline. We will also update the summary of the first 1,350 responses to reflect all responses. We’re also exploring ways to make the valuable data set available to researchers.
- Respond to the FDA Docket: We’ve made it easy to provide input directly to FDA. Read the step-by-step instructions here or visit the docket site directly.